Details for New Drug Application (NDA): 064146
✉ Email this page to a colleague
NDA 064146 describes AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.
The generic ingredient in AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is amikacin sulfate. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
The generic ingredient in AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is amikacin sulfate. There are fifteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the amikacin sulfate profile page.
Summary for 064146
| Tradename: | AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER |
| Applicant: | Hospira |
| Ingredient: | amikacin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 064146
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/100ML | ||||
| Approval Date: | Apr 2, 1997 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
